| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | glycogen phosphorylase activity | 3.61e-08 | 3 | 67 | 3 | GO:0008184 | |
| GeneOntologyMolecularFunction | 1,4-alpha-oligoglucan phosphorylase activity | 3.59e-07 | 5 | 67 | 3 | GO:0004645 | |
| GeneOntologyMolecularFunction | pyridoxal phosphate binding | 3.73e-05 | 56 | 67 | 4 | GO:0030170 | |
| GeneOntologyMolecularFunction | vitamin B6 binding | 4.00e-05 | 57 | 67 | 4 | GO:0070279 | |
| GeneOntologyMolecularFunction | translation termination factor activity | 2.30e-04 | 7 | 67 | 2 | GO:0008079 | |
| GeneOntologyMolecularFunction | translation release factor activity | 2.30e-04 | 7 | 67 | 2 | GO:0003747 | |
| Domain | PHOSPHORYLASE | 4.02e-08 | 3 | 65 | 3 | PS00102 | |
| Domain | Phosphorylase | 4.02e-08 | 3 | 65 | 3 | PF00343 | |
| Domain | Glycg_phsphrylas | 4.02e-08 | 3 | 65 | 3 | IPR011833 | |
| Domain | Glyco_trans_35 | 4.02e-08 | 3 | 65 | 3 | IPR000811 | |
| Domain | TRPV5/TRPV6 | 1.19e-05 | 2 | 65 | 2 | IPR008344 | |
| Domain | Pep_chain_release_fac_I_II | 7.12e-05 | 4 | 65 | 2 | IPR000352 | |
| Domain | RF-1 | 7.12e-05 | 4 | 65 | 2 | PF00472 | |
| Domain | RF_PROK_I | 7.12e-05 | 4 | 65 | 2 | PS00745 | |
| Domain | TRP_channel | 6.43e-04 | 11 | 65 | 2 | IPR004729 | |
| Pathway | KEGG_MEDICUS_REFERENCE_GLYCOGEN_DEGRADATION | 3.27e-06 | 9 | 49 | 3 | M47621 | |
| Pathway | REACTOME_GLYCOGEN_BREAKDOWN_GLYCOGENOLYSIS | 1.40e-05 | 14 | 49 | 3 | M19193 | |
| Pathway | REACTOME_GLYCOGEN_METABOLISM | 8.60e-05 | 25 | 49 | 3 | M27857 | |
| Pathway | WP_GLYCOGEN_METABOLISM | 2.19e-04 | 34 | 49 | 3 | MM15985 | |
| Pubmed | PML interacts with Myc, and Myc target gene expression is altered in PML-null fibroblasts. | 1.00e-06 | 37 | 71 | 4 | 15735755 | |
| Pubmed | 3.64e-06 | 15 | 71 | 3 | 2575583 | ||
| Pubmed | 4.11e-06 | 2 | 71 | 2 | 20178461 | ||
| Pubmed | 4.11e-06 | 2 | 71 | 2 | 22354706 | ||
| Pubmed | Diverse calcium channel types are present in the human placental syncytiotrophoblast basal membrane. | 4.11e-06 | 2 | 71 | 2 | 16564089 | |
| Pubmed | Endogenous expression of TRPV5 and TRPV6 calcium channels in human leukemia K562 cells. | 4.11e-06 | 2 | 71 | 2 | 19295174 | |
| Pubmed | Human TRPV5 and TRPV6: key players in cadmium and zinc toxicity. | 4.11e-06 | 2 | 71 | 2 | 23968883 | |
| Pubmed | 4.11e-06 | 2 | 71 | 2 | 12390878 | ||
| Pubmed | TRPV5 and TRPV6 are expressed in placenta and bone tissues during pregnancy in mice. | 4.11e-06 | 2 | 71 | 2 | 30916584 | |
| Pubmed | 4.11e-06 | 2 | 71 | 2 | 19272297 | ||
| Pubmed | 4.11e-06 | 2 | 71 | 2 | 16565876 | ||
| Pubmed | Age-dependent alterations in Ca2+ homeostasis: role of TRPV5 and TRPV6. | 4.11e-06 | 2 | 71 | 2 | 16705151 | |
| Pubmed | 4.11e-06 | 2 | 71 | 2 | 20405023 | ||
| Pubmed | A single amino acid mutation results in a rapid inactivation of epithelial calcium channels. | 4.11e-06 | 2 | 71 | 2 | 11846401 | |
| Pubmed | 4.11e-06 | 2 | 71 | 2 | 24761864 | ||
| Pubmed | 4.11e-06 | 2 | 71 | 2 | 12077127 | ||
| Pubmed | 4.11e-06 | 2 | 71 | 2 | 24592736 | ||
| Pubmed | 4.11e-06 | 2 | 71 | 2 | 22821833 | ||
| Pubmed | Homo- and heterotetrameric architecture of the epithelial Ca2+ channels TRPV5 and TRPV6. | 4.11e-06 | 2 | 71 | 2 | 12574114 | |
| Pubmed | Structural conservation of the genes encoding CaT1, CaT2, and related cation channels. | 4.11e-06 | 2 | 71 | 2 | 11549322 | |
| Pubmed | 4.11e-06 | 2 | 71 | 2 | 19140341 | ||
| Pubmed | 4.11e-06 | 2 | 71 | 2 | 25164318 | ||
| Pubmed | Regulation of the mouse epithelial Ca2(+) channel TRPV6 by the Ca(2+)-sensor calmodulin. | 4.11e-06 | 2 | 71 | 2 | 15123711 | |
| Pubmed | 4.11e-06 | 2 | 71 | 2 | 25130497 | ||
| Pubmed | Single-channel activities of the human epithelial Ca2+ transport proteins CaT1 and CaT2. | 4.11e-06 | 2 | 71 | 2 | 11719848 | |
| Pubmed | Concerted action of associated proteins in the regulation of TRPV5 and TRPV6. | 4.11e-06 | 2 | 71 | 2 | 17233615 | |
| Pubmed | Transcriptional activation of hTERT in breast carcinomas by the Her2-ER81-related pathway. | 1.23e-05 | 3 | 71 | 2 | 19718948 | |
| Pubmed | 1.23e-05 | 3 | 71 | 2 | 10610704 | ||
| Pubmed | 1.23e-05 | 3 | 71 | 2 | 17200157 | ||
| Pubmed | 1.23e-05 | 3 | 71 | 2 | 25951185 | ||
| Pubmed | Age-dependent changes in the expression of klotho protein, TRPV5 and TRPV6 in mouse inner ear. | 1.23e-05 | 3 | 71 | 2 | 19922080 | |
| Pubmed | Identification of BSPRY as a novel auxiliary protein inhibiting TRPV5 activity. | 1.23e-05 | 3 | 71 | 2 | 16380433 | |
| Pubmed | A molecular determinant of phosphoinositide affinity in mammalian TRPV channels. | 1.23e-05 | 3 | 71 | 2 | 27291418 | |
| Pubmed | A feed-forward loop between SorLA and HER3 determines heregulin response and neratinib resistance. | 1.23e-05 | 3 | 71 | 2 | 33420373 | |
| Pubmed | 1.23e-05 | 3 | 71 | 2 | 17978477 | ||
| Pubmed | Calbindin-D28K dynamically controls TRPV5-mediated Ca2+ transport. | 1.23e-05 | 3 | 71 | 2 | 16763551 | |
| Pubmed | 1.23e-05 | 3 | 71 | 2 | 16354700 | ||
| Pubmed | Analysis of a lung defect in autophagy-deficient mouse strains. | 2.05e-05 | 26 | 71 | 3 | 24275123 | |
| Pubmed | Mutations in C12orf65 in patients with encephalomyopathy and a mitochondrial translation defect. | 2.46e-05 | 4 | 71 | 2 | 20598281 | |
| Pubmed | 2.46e-05 | 4 | 71 | 2 | 19787269 | ||
| Pubmed | hTERT regulation by NF-κB and c-myc in irradiated HER2-positive breast cancer cells. | 2.46e-05 | 4 | 71 | 2 | 21627565 | |
| Pubmed | 2.46e-05 | 4 | 71 | 2 | 12660155 | ||
| Pubmed | 2.46e-05 | 4 | 71 | 2 | 34110646 | ||
| Pubmed | Characterising the dynamics of placental glycogen stores in the mouse. | 2.87e-05 | 29 | 71 | 3 | 32798765 | |
| Pubmed | Network organization of the huntingtin proteomic interactome in mammalian brain. | 3.91e-05 | 621 | 71 | 8 | 22794259 | |
| Pubmed | Role and regulation of TRP channels in neutrophil granulocytes. | 4.09e-05 | 5 | 71 | 2 | 12765698 | |
| Pubmed | 4.09e-05 | 5 | 71 | 2 | 22407925 | ||
| Pubmed | 4.09e-05 | 5 | 71 | 2 | 7507509 | ||
| Pubmed | Noncanonical Effects of IRF9 in Intestinal Inflammation: More than Type I and Type III Interferons. | 4.09e-05 | 5 | 71 | 2 | 25918247 | |
| Pubmed | 6.05e-05 | 331 | 71 | 6 | 29199018 | ||
| Pubmed | Cyclin M2 (CNNM2) knockout mice show mild hypomagnesaemia and developmental defects. | 1.14e-04 | 8 | 71 | 2 | 33859252 | |
| Pubmed | 1.47e-04 | 9 | 71 | 2 | 32601248 | ||
| Pubmed | USP9X-mediated NRP1 deubiquitination promotes liver fibrosis by activating hepatic stellate cells. | 1.83e-04 | 10 | 71 | 2 | 36653359 | |
| Pubmed | 2.51e-04 | 430 | 71 | 6 | 16303743 | ||
| Pubmed | A dual role of erbB2 in myelination and in expansion of the schwann cell precursor pool. | 2.68e-04 | 12 | 71 | 2 | 10704452 | |
| Pubmed | 2.68e-04 | 12 | 71 | 2 | 16364241 | ||
| Pubmed | 3.16e-04 | 13 | 71 | 2 | 22266179 | ||
| Pubmed | 4.24e-04 | 15 | 71 | 2 | 18760695 | ||
| Pubmed | 4.84e-04 | 16 | 71 | 2 | 26263173 | ||
| Pubmed | 4.84e-04 | 16 | 71 | 2 | 2037298 | ||
| Pubmed | Tat protein induces self-perpetuating permissivity for productive HIV-1 infection. | 4.84e-04 | 16 | 71 | 2 | 9223324 | |
| Pubmed | Quantitative high-confidence human mitochondrial proteome and its dynamics in cellular context. | 4.96e-04 | 1136 | 71 | 9 | 34800366 | |
| Pubmed | 5.28e-04 | 323 | 71 | 5 | 24797263 | ||
| Pubmed | 5.48e-04 | 17 | 71 | 2 | 12693554 | ||
| Pubmed | Genome-wide pleiotropy of osteoporosis-related phenotypes: the Framingham Study. | 5.48e-04 | 17 | 71 | 2 | 20200953 | |
| Pubmed | Mitochondrial protein interactome elucidated by chemical cross-linking mass spectrometry. | 6.93e-04 | 343 | 71 | 5 | 28130547 | |
| Pubmed | 9.27e-04 | 93 | 71 | 3 | 27215380 | ||
| Pubmed | Mapping the expression of transient receptor potential channels across murine placental development. | 1.10e-03 | 24 | 71 | 2 | 33884443 | |
| Pubmed | 1.20e-03 | 25 | 71 | 2 | 16382100 | ||
| Pubmed | A mitochondrial protein compendium elucidates complex I disease biology. | 1.31e-03 | 1047 | 71 | 8 | 18614015 | |
| Pubmed | SCAP knockout in SM22α-Cre mice induces defective angiogenesis in the placental labyrinth. | 1.40e-03 | 27 | 71 | 2 | 33227706 | |
| Pubmed | 1.40e-03 | 27 | 71 | 2 | 16460286 | ||
| Pubmed | 1.61e-03 | 29 | 71 | 2 | 28364022 | ||
| Pubmed | Identification of Zika Virus and Dengue Virus Dependency Factors using Functional Genomics. | 1.73e-03 | 422 | 71 | 5 | 27342126 | |
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | 1.83e-03 | 1105 | 71 | 8 | 35748872 | |
| Pubmed | Specific functions for ERK/MAPK signaling during PNS development. | 1.84e-03 | 31 | 71 | 2 | 21220101 | |
| Cytoband | 11q13.2 | 5.47e-05 | 47 | 71 | 3 | 11q13.2 | |
| Cytoband | 1q32.1 | 6.44e-04 | 108 | 71 | 3 | 1q32.1 | |
| Cytoband | 5p15.33 | 1.14e-03 | 32 | 71 | 2 | 5p15.33 | |
| Cytoband | 14q11.2 | 2.79e-03 | 180 | 71 | 3 | 14q11.2 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr7q34 | 3.01e-03 | 185 | 71 | 3 | chr7q34 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr11q13 | 5.44e-03 | 454 | 71 | 4 | chr11q13 | |
| Cytoband | 6p21.1 | 6.89e-03 | 80 | 71 | 2 | 6p21.1 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr6p21 | 7.76e-03 | 503 | 71 | 4 | chr6p21 | |
| GeneFamily | Glycogen phosphorylases | 1.44e-08 | 3 | 45 | 3 | 437 | |
| GeneFamily | Transient receptor potential cation channels | 2.20e-03 | 28 | 45 | 2 | 249 | |
| GeneFamily | Endogenous ligands|Minor histocompatibility antigens | 7.15e-03 | 51 | 45 | 2 | 870 | |
| GeneFamily | Adenosine receptors|V-set domain containing | 7.74e-03 | 163 | 45 | 3 | 590 | |
| Coexpression | CAIRO_PML_TARGETS_BOUND_BY_MYC_DN | 3.47e-08 | 13 | 71 | 4 | M1117 | |
| Coexpression | CAIRO_PML_TARGETS_BOUND_BY_MYC_DN | 3.47e-08 | 13 | 71 | 4 | MM1098 | |
| Coexpression | ALCALA_APOPTOSIS | 3.93e-06 | 87 | 71 | 5 | M16169 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell-Distal_Convoluted_Tubule_Cell_Type_2|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 5.41e-06 | 158 | 71 | 5 | 7960337d87afecf2692ab65e5991f052ceddfacc | |
| ToppCell | 5'-Adult-SmallIntestine-Epithelial-neuro-epithelial-EECs|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 6.11e-06 | 162 | 71 | 5 | 478cf560ef33c5c324142c76417447d4a571a2c9 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell-Distal_Convoluted_Tubule_Cell_Type_2|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.10e-05 | 183 | 71 | 5 | 2e831a4d99c6f983793df71c0994124c943c6da9 | |
| ToppCell | droplet-Kidney-nan-18m-Epithelial-kidney_collecting_duct_principal_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.32e-05 | 190 | 71 | 5 | c408d4033a130c0168159a5b6f286fd2b2a9a39d | |
| ToppCell | droplet-Kidney-nan-18m-Epithelial-Epcam____kidney_collecting_duct_principal_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.32e-05 | 190 | 71 | 5 | d4910c37045a8b8bb53b37625263bc0a47b6e3f8 | |
| Drug | 3,5-dimethylphenyl isocyanate | 2.78e-08 | 3 | 70 | 3 | CID000521488 | |
| Drug | 5-ethyl-4-hydroxy-2-methyl-3(2H)-furanone | 2.78e-08 | 3 | 70 | 3 | CID000093111 | |
| Drug | adenosine-5'-chloromethylphosphonate | 2.78e-08 | 3 | 70 | 3 | CID000191554 | |
| Drug | hydan | 2.78e-08 | 3 | 70 | 3 | CID000008360 | |
| Drug | EHMF | 2.78e-08 | 3 | 70 | 3 | CID000033931 | |
| Drug | 5'-deoxy-5'-fluoro-5'-(methylthio)adenosine | 2.78e-08 | 3 | 70 | 3 | CID000147839 | |
| Drug | pyridoxal 5'-methylenephosphonate | 2.78e-08 | 3 | 70 | 3 | CID003082249 | |
| Drug | Plp 5'-mpa | 2.78e-08 | 3 | 70 | 3 | CID003082151 | |
| Drug | glucose-1,2-cyclic phosphate | 2.78e-08 | 3 | 70 | 3 | CID000191723 | |
| Drug | 3'-FFdUrd | 2.78e-08 | 3 | 70 | 3 | CID000072260 | |
| Drug | 2',3',4',5,5'-pentachloro-2-biphenylol | 2.78e-08 | 3 | 70 | 3 | CID000119518 | |
| Drug | AC1L8XK3 | 2.78e-08 | 3 | 70 | 3 | CID000409735 | |
| Drug | N-acetyl-N'-beta-D-glucopyranosyl urea | 2.78e-08 | 3 | 70 | 3 | CID000446801 | |
| Drug | NSC758405 | 2.78e-08 | 3 | 70 | 3 | CID000003201 | |
| Drug | 3,5-dinitrophenyl phosphate | 2.78e-08 | 3 | 70 | 3 | CID000151920 | |
| Drug | riboflavin tetraacetate | 2.78e-08 | 3 | 70 | 3 | CID000094186 | |
| Drug | pyridoxal phosphoglucose | 2.78e-08 | 3 | 70 | 3 | CID000196007 | |
| Drug | 2,5-dimethyl-3-furanone | 2.78e-08 | 3 | 70 | 3 | CID000085730 | |
| Drug | 3,5-dinitrophenol | 2.78e-08 | 3 | 70 | 3 | CID000011459 | |
| Drug | sotolon | 1.09e-07 | 15 | 70 | 4 | CID000062835 | |
| Drug | galocitabine | 1.11e-07 | 4 | 70 | 3 | CID000065950 | |
| Drug | 2,5-anhydro-D-mannitol 1-phosphate | 1.11e-07 | 4 | 70 | 3 | CID000189134 | |
| Drug | AC1LAMW2 | 1.11e-07 | 4 | 70 | 3 | CID000491364 | |
| Drug | FdUrd-C8 | 1.11e-07 | 4 | 70 | 3 | CID000094262 | |
| Drug | Mem-CC | 1.11e-07 | 4 | 70 | 3 | CID003081269 | |
| Drug | 5-deoxyribose-1-phosphate | 1.11e-07 | 4 | 70 | 3 | CID000135786 | |
| Drug | ingliforib | 1.11e-07 | 4 | 70 | 3 | CID006451325 | |
| Drug | uric acid riboside | 1.11e-07 | 4 | 70 | 3 | CID000164933 | |
| Drug | pseudo-dl-glucose | 1.11e-07 | 4 | 70 | 3 | CID000125259 | |
| Drug | BCIp4A | 1.11e-07 | 4 | 70 | 3 | CID000192417 | |
| Drug | pyridoxal diphosphate | 1.11e-07 | 4 | 70 | 3 | CID000125696 | |
| Drug | 3'-chloromethotrexate | 1.11e-07 | 4 | 70 | 3 | CID000097703 | |
| Drug | F-6b | 1.45e-07 | 16 | 70 | 4 | CID000004288 | |
| Drug | heptulose-2-P | 2.77e-07 | 5 | 70 | 3 | CID000124823 | |
| Drug | m-anisidine | 2.77e-07 | 5 | 70 | 3 | CID000010824 | |
| Drug | 6-FPLP | 2.77e-07 | 5 | 70 | 3 | CID000146246 | |
| Drug | gluconohydroximo-1,5-lactone | 2.77e-07 | 5 | 70 | 3 | CID009576855 | |
| Drug | 2-hydroxypropylphosphonate | 2.77e-07 | 5 | 70 | 3 | CID000441028 | |
| Drug | DHPBU | 2.77e-07 | 5 | 70 | 3 | CID000125914 | |
| Drug | 6-FDPL | 2.77e-07 | 5 | 70 | 3 | CID000129578 | |
| Drug | 5'-isobutylthioinosine | 2.77e-07 | 5 | 70 | 3 | CID003080910 | |
| Drug | 3'-O-methylpyridoxal 5'-phosphate | 2.77e-07 | 5 | 70 | 3 | CID003082179 | |
| Drug | GlcMan | 2.77e-07 | 5 | 70 | 3 | CID000152120 | |
| Drug | U66985 | 2.77e-07 | 5 | 70 | 3 | CID000127224 | |
| Drug | indirubin-5-sulphonate | 2.77e-07 | 5 | 70 | 3 | CID005288641 | |
| Drug | AC1O3M08 | 2.77e-07 | 5 | 70 | 3 | CID006331955 | |
| Drug | AC1LCUXJ | 2.77e-07 | 5 | 70 | 3 | CID000656425 | |
| Drug | 6-amino-5-bromouracil | 2.77e-07 | 5 | 70 | 3 | CID000080578 | |
| Drug | etafenone | 2.77e-07 | 5 | 70 | 3 | CID000003275 | |
| Drug | ddEtUrd | 2.77e-07 | 5 | 70 | 3 | CID000451452 | |
| Drug | 5-trifluoromethyl-2'-deoxycytidine | 2.77e-07 | 5 | 70 | 3 | CID000125618 | |
| Drug | CV-araU | 5.53e-07 | 6 | 70 | 3 | CID006441877 | |
| Drug | 2-thiothymidine | 5.53e-07 | 6 | 70 | 3 | CID003005944 | |
| Drug | Carbocyclic Bvdc | 5.53e-07 | 6 | 70 | 3 | CID006438602 | |
| Drug | DNPP | 5.53e-07 | 6 | 70 | 3 | CID000067056 | |
| Drug | 5-chloro-indole-2-carboxylic acid | 5.53e-07 | 6 | 70 | 3 | CID000082693 | |
| Drug | 2,2-dimethyl-3-hydroxybutyric acid | 5.53e-07 | 6 | 70 | 3 | CID000152984 | |
| Drug | EdUMP | 5.53e-07 | 6 | 70 | 3 | CID003085112 | |
| Drug | 5'-deoxy-5'-chloroformycin | 5.53e-07 | 6 | 70 | 3 | CID000126430 | |
| Drug | NSC-97433 | 5.53e-07 | 6 | 70 | 3 | CID000001803 | |
| Drug | 5-n-propylthioadenosine | 5.53e-07 | 6 | 70 | 3 | CID000656428 | |
| Drug | AzddCyd | 5.53e-07 | 6 | 70 | 3 | CID000451374 | |
| Drug | 5-Ffdru | 5.53e-07 | 6 | 70 | 3 | CID000065561 | |
| Drug | AR-L57 | 5.53e-07 | 6 | 70 | 3 | CID000156890 | |
| Drug | Carbocyclic Ivdu | 5.53e-07 | 6 | 70 | 3 | CID006439191 | |
| Drug | Pyridoxal Phosphate | 6.08e-07 | 53 | 70 | 5 | DB00114 | |
| Drug | BrVarafUTP | 8.31e-07 | 24 | 70 | 4 | CID005273539 | |
| Drug | alpha-(fluoromethyl)dehydroornithine | 9.66e-07 | 7 | 70 | 3 | CID006439607 | |
| Drug | 6-fluoropyridoxal | 9.66e-07 | 7 | 70 | 3 | CID003080803 | |
| Drug | 2',3'-dideoxy-3'-fluorocytidine | 9.66e-07 | 7 | 70 | 3 | CID000356019 | |
| Drug | heptenitol | 9.66e-07 | 7 | 70 | 3 | CID000188267 | |
| Drug | AC1L3372 | 9.66e-07 | 7 | 70 | 3 | CID000108025 | |
| Drug | 1 Gpt | 9.66e-07 | 7 | 70 | 3 | CID000101247 | |
| Drug | formycins | 9.66e-07 | 7 | 70 | 3 | CID000512867 | |
| Drug | Promonta | 9.66e-07 | 7 | 70 | 3 | CID000108494 | |
| Drug | 5'-methylthioinosine | 9.66e-07 | 7 | 70 | 3 | CID000161214 | |
| Drug | hydantocidin | 9.66e-07 | 7 | 70 | 3 | CID000125429 | |
| Drug | FUTP | 1.36e-06 | 27 | 70 | 4 | CID000122060 | |
| Drug | AC1NUVX5 | 1.54e-06 | 8 | 70 | 3 | CID005461894 | |
| Drug | 6-methylpurine | 1.54e-06 | 8 | 70 | 3 | CID005287547 | |
| Drug | amorphin | 1.54e-06 | 8 | 70 | 3 | CID000122792 | |
| Drug | Etafenone [inn] | 1.54e-06 | 8 | 70 | 3 | CID000066659 | |
| Drug | 6-benzyl-2-thiouracil | 2.31e-06 | 9 | 70 | 3 | CID000685814 | |
| Drug | 5'-methylthiotubercidin | 2.31e-06 | 9 | 70 | 3 | CID000188350 | |
| Drug | alpha-maltosyl fluoride | 2.31e-06 | 9 | 70 | 3 | CID000194237 | |
| Drug | 5-Iodoribose 1-phosphate | 2.31e-06 | 9 | 70 | 3 | CID003035973 | |
| Drug | 5'-iodo-5'-deoxyadenosine | 2.31e-06 | 9 | 70 | 3 | CID000107502 | |
| Drug | 8-azidoadenosine 5'-monophosphate | 3.29e-06 | 10 | 70 | 3 | CID000124726 | |
| Drug | 2,6-dihydroxypyridine | 3.29e-06 | 10 | 70 | 3 | CID000069371 | |
| Drug | 6-methyluridine | 3.29e-06 | 10 | 70 | 3 | CID000092887 | |
| Drug | UDP-pyridoxal | 3.29e-06 | 10 | 70 | 3 | CID000126789 | |
| Drug | alpha-ketoisocaproate | 4.49e-06 | 79 | 70 | 5 | CID000000070 | |
| Drug | glucosyl fluoride | 4.51e-06 | 11 | 70 | 3 | CID000150967 | |
| Drug | Cid 11299980 | 4.51e-06 | 11 | 70 | 3 | CID009856533 | |
| Drug | 9 Da | 4.51e-06 | 11 | 70 | 3 | CID005287565 | |
| Drug | L-BVAU | 5.59e-06 | 38 | 70 | 4 | CID000667554 | |
| Drug | BCX-34 | 6.00e-06 | 12 | 70 | 3 | CID000060817 | |
| Drug | Ap4U | 6.00e-06 | 12 | 70 | 3 | CID000165888 | |
| Drug | phenylurethane | 6.00e-06 | 12 | 70 | 3 | CID000007591 | |
| Drug | acyclothymidine | 6.00e-06 | 12 | 70 | 3 | CID000072358 | |
| Disease | Mitochondrial Encephalomyopathies | 1.45e-04 | 8 | 68 | 2 | C0162666 | |
| Disease | aplastic anemia (is_marker_for) | 1.86e-04 | 9 | 68 | 2 | DOID:12449 (is_marker_for) | |
| Disease | Sclerocystic Ovaries | 3.48e-04 | 144 | 68 | 4 | C1136382 | |
| Disease | Polycystic Ovary Syndrome | 3.48e-04 | 144 | 68 | 4 | C0032460 | |
| Disease | transitional cell carcinoma (is_marker_for) | 4.21e-04 | 63 | 68 | 3 | DOID:2671 (is_marker_for) | |
| Disease | glycerate measurement | 5.39e-04 | 15 | 68 | 2 | EFO_0021029 | |
| Disease | Malignant Glioma | 5.74e-04 | 70 | 68 | 3 | C0555198 | |
| Disease | mixed gliomas | 5.74e-04 | 70 | 68 | 3 | C0259783 | |
| Disease | urinary bladder cancer (is_implicated_in) | 7.30e-04 | 76 | 68 | 3 | DOID:11054 (is_implicated_in) | |
| Disease | telomere length | 7.85e-04 | 313 | 68 | 5 | EFO_0004505 | |
| Disease | macula measurement | 9.64e-04 | 189 | 68 | 4 | EFO_0008375 | |
| Disease | myelodysplastic syndrome (is_marker_for) | 9.68e-04 | 20 | 68 | 2 | DOID:0050908 (is_marker_for) | |
| Disease | Glioma | 1.08e-03 | 87 | 68 | 3 | C0017638 | |
| Disease | Intrahepatic Cholangiocarcinoma | 1.40e-03 | 24 | 68 | 2 | C0345905 | |
| Disease | Extrahepatic Cholangiocarcinoma | 1.40e-03 | 24 | 68 | 2 | C3805278 | |
| Disease | Cholangiocarcinoma | 1.64e-03 | 26 | 68 | 2 | C0206698 | |
| Disease | Glycogen Storage Disease | 1.77e-03 | 27 | 68 | 2 | C0017919 | |
| Disease | Pigmented Basal Cell Carcinoma | 1.90e-03 | 28 | 68 | 2 | C1368275 | |
| Disease | hepatocellular carcinoma (biomarker_via_orthology) | 2.01e-03 | 108 | 68 | 3 | DOID:684 (biomarker_via_orthology) | |
| Disease | anxiety measurement | 2.01e-03 | 108 | 68 | 3 | EFO_0009863 | |
| Disease | Carcinoma, Basal Cell | 2.04e-03 | 29 | 68 | 2 | C4721806 | |
| Disease | Cholestasis | 2.12e-03 | 110 | 68 | 3 | C0008370 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| LCRWGLLLALLPPGA | 6 | P04626 | |
| CISWQRPTGIPLGNL | 166 | Q9N2K0 | |
| MLCRLGGRWLRPLPA | 1 | Q8N8Q8 | |
| SGIQRLPWAELICPR | 171 | Q8TER5 | |
| LEPLARGKRWILQPC | 161 | Q9NXU5 | |
| RGGCWPRGLQQLLVP | 11 | Q9Y4W6 | |
| PLPCPLLLALRWGLT | 276 | O00155 | |
| RWQGCTRPALLAPSL | 136 | P86434 | |
| IAWVRICRPGLVIGP | 311 | A4D256 | |
| PAQWPGITCLIRLLN | 2291 | Q9Y485 | |
| GWLCKTLRLNQPGTP | 381 | P36507 | |
| CARRRRPGLLLPGLW | 36 | Q9HCM3 | |
| LPGLWLLLLARPASC | 46 | Q9HCM3 | |
| GRLLGRWKALLIPPS | 891 | Q96GW7 | |
| LGRWLCLGTLPRPRA | 491 | A6NCF5 | |
| LLLCLWLPSGRAALP | 26 | Q86VZ4 | |
| LFWRTCGRPALPVLG | 421 | Q6DN14 | |
| PILSCGGLAKRWLVP | 271 | P17735 | |
| RWGPLLLCLLQAAPG | 6 | Q8IU57 | |
| LPLGPLLLHRCCQLW | 251 | Q96T55 | |
| SRRLWLGPQCSKLPL | 56 | P0DMR3 | |
| WGIVQGQLRPLLAPR | 4436 | Q15751 | |
| LPLWLPRGCSGILSV | 26 | Q6ZUT6 | |
| LPTLPGTLCLRIFRW | 131 | P58166 | |
| LWNYVPGLTPCLPRR | 1611 | O75037 | |
| QGPRGLALRLWPKLQ | 246 | Q8N2G8 | |
| PALRSLRLDGNPWLC | 176 | Q5VT99 | |
| VRRLGCLLERLPWSP | 356 | Q02509 | |
| CTLLAGNPIPERRWI | 911 | Q96RW7 | |
| QGGPRPRQLLLWLLI | 6 | Q9Y5I0 | |
| LLAWRPGCLRALGGP | 411 | Q9BZG2 | |
| VLGPALLCRPWEVLG | 16 | P51553 | |
| CKLPGRLRIQPALWS | 41 | Q9Y603 | |
| GVTDLRLWLCQPAPR | 21 | Q6B9Z1 | |
| LSRAGVWLLPPPARC | 11 | Q14197 | |
| CPPIGRRAATALLWL | 21 | O95467 | |
| RGLFVQRLCPIPISW | 286 | Q00978 | |
| GPWARLLLPRLLRCL | 71 | Q86Y56 | |
| LLTLRAWRRGVCPPG | 326 | Q6UY11 | |
| ARKLLSVPWLLCGPR | 11 | O15382 | |
| LCLSLGVPGWRRPTT | 16 | P55291 | |
| RPNLSLPLVRCGWAC | 91 | P0C7U9 | |
| SRPWVFGPLLCRLSL | 101 | O43193 | |
| LLPPGALCEVWTQRL | 21 | Q92673 | |
| LLLLLLWPQGCVSGP | 6 | Q5T2D2 | |
| LKRRPWLGAPLQVGL | 256 | Q9BWM7 | |
| PCLCLLGPNLKAWLR | 126 | Q07326 | |
| LCRLVGPYVPLWLGQ | 386 | Q8N2H9 | |
| GQPRLCRQPLTRALW | 11 | Q9BWN1 | |
| PPARLSLSWRGLTLC | 281 | Q9Y336 | |
| CALAWRLGGRPQPLL | 16 | Q9H7Z7 | |
| WCRLATVPRLVLGPE | 61 | Q8N4L1 | |
| ILALCAGLPPLLRAW | 66 | Q96K37 | |
| LLPLRPGCGERPLAW | 846 | Q9Y2I6 | |
| FLIPRAGWLAGLLCP | 101 | Q96JT2 | |
| GSLWVRTQLGLPPLL | 6 | Q9BXS4 | |
| PTPGAQRLCRLSVWI | 226 | Q5GH73 | |
| TPLTRICPAPWGLRL | 11 | Q9H3J6 | |
| GITPRRWLVLCNPGL | 486 | P11217 | |
| RSNLGWLCLLLLPIP | 171 | P25445 | |
| RPGLCALWDPLSLLR | 671 | Q96PX9 | |
| KGIPSALRARCWPLL | 91 | Q8IV04 | |
| RWGCRLLALLLLVPG | 16 | Q9Y3B3 | |
| GITPRRWLLLCNPGL | 486 | P11216 | |
| RKLPRCLWPRSGICG | 646 | Q9H1D0 | |
| ALLALALLPWRCPPG | 381 | C9JH25 | |
| LEGCGPPLRRWLRAN | 276 | Q9H1Z9 | |
| LGSPWAVELPLCGRR | 6 | Q9BUB7 | |
| GITPRRWLLLCNPGL | 486 | P06737 | |
| LLVPGLPCLVRGGWP | 46 | Q96NR7 | |
| RACLRRLVPPGLWGS | 466 | O14746 | |
| GGLLCALLTLRWPRP | 156 | Q66K66 | |
| RKLPRCLWPRSGICG | 606 | Q9NQA5 |